Mavyret is a fixed dose combination of the direct-acting antiviral agents, glecaprevir, a HCV NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor.

A small molecule binds to an OX2 protein. The new foundation model Boltz-2, developed by researchers at MIT and Recursion, achieves state-of-the-art performance in protein binding affinity ...

While the α-helix structure percentage in BSA decreased during interaction with SiNPs, parallel β-sheet protein confirmation was increasingly favored.

The New York State Department of Health is observing May as Hepatitis Awareness Month, emphasizing its ongoing efforts to eradicate hepatitis C.

Florida health officials say three hepatitis C cases may have been caused by unsterilized instruments and/or equipment during procedures.

The Florida Department of Health in Brevard County posted a notification of potential hepatitis C exposure to patients who received treatment at a Melbourne clinic.

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s premier testing laboratory for viral hepatitis, experts warned.

Atea Pharmaceuticals Announces Dosing of First Patient in C-BEYOND, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus ...

In this Review, we summarise outputs from a multidisciplinary consultation convened by WHO between July 11 and 13, 2023, to discuss hepatitis B virus (HBV) drug resistance (HBVDR). Treatment of ...

Learn about hepatitis C, how it spreads, possible symptoms, and important steps to protect yourself and others from this virus.

Hepatitis B virus is protected by a spiky shell called the capsid, made of HBc proteins. This structure is critical for survival, and therefore a promising therapeutic target. Current approaches rely ...